Track Levetiracetam Price Trend Historical and Forecast

Levetiracetam Price Trend and Forecast: Global Analysis and Market Outlook

Executive Summary

The global Levetiracetam market has witnessed notable price movements throughout 2024 and 2025, driven by a combination of rising import costs, freight fluctuations, inventory dynamics, and firm pharmaceutical demand. For the quarter ending September 2025, Levetiracetam prices demonstrated upward trends in North America, APAC, and Europe, albeit with regional nuances influenced by supply disruptions, currency fluctuations, and restocking behavior.

In North America, elevated import costs and constrained Asian exports underpinned price increases, while in APAC, supply interruptions from flood-induced plant closures and subsequent production resumption contributed to volatility. Europe's market reflected a moderate upward trend driven by import costs, steady pharmaceutical procurement, and cautious inventory management.

◼ Get Instant Access to Live Levetiracetam Prices Today: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Levetiracetam

Introduction

Levetiracetam, an antiepileptic drug widely used in neurological and psychiatric treatment, has seen its market evolve amid global economic shifts, fluctuating logistics costs, and region-specific supply constraints. The active pharmaceutical ingredient (API) sector relies heavily on imports from Asia, particularly China, making global trade dynamics a key determinant of price behavior.

From Q4 2024 through Q3 2025, Levetiracetam pricing demonstrated a mixture of stability, moderate upward trends, and temporary volatility influenced by environmental events, import tariffs, and currency movements. Understanding these price dynamics is critical for formulators, distributors, and procurement managers who aim to optimize sourcing strategies and maintain cost-effective supply chains.

Global Price Overview

As of September 2025, global Levetiracetam prices averaged in the range of USD 30,233-30,270/MT, reflecting an overall upward bias driven by import cost inflation, freight pressures, and restocking activity. Across major markets:

North America: USD 30,263.33/MT (CFR/Spot basis)
APAC (China): USD 30,233.33/MT (FOB Shanghai)
Europe (Germany): USD 30,270.67/MT (CFR Hamburg)
Quarter-over-quarter, the price indices in North America, APAC, and Europe rose by 2.45%, 2.83%, and 2.64%, respectively, reflecting synchronized global pressures. Intramonth spot price volatility was observed across regions, influenced by variations in freight rates, supplier availability, and inventory adjustments.

◼ Monitor Real-Time Levetiracetam Price Swings and Stay Ahead of Competitors: https://www.chemanalyst.com/Pricing-data/levetiracetam-1641

Regional Analysis

North America

Q3 2025 (July-September)

In the United States, the Levetiracetam Price Index rose 2.45% quarter-over-quarter, primarily due to higher import costs, elevated freight charges, and steady downstream pharmaceutical demand. The average price for Q3 2025 reached USD 30,263.33/MT, with spot prices showing intramonth volatility as Chinese export offers and freight variations altered landed procurement economics.

Price Drivers:

Higher import costs: Rising FOB prices from Asian suppliers and freight rate inflation increased landed costs.
Export constraints: Limited availability from Asia prompted urgent restocking.
Inventory effects: Elevated domestic stocks intermittently pressured prices, though strategic replenishment sustained transactional momentum.
Demand Outlook: Robust procurement from API producers and pharmaceutical formulators supported a constructive demand environment. Buyers demonstrated cautious purchasing behavior amid elevated inventories, moderating spot buying pressure.

Q2 2025 (April-June)

The North American market witnessed an upward shift in July 2025 as Levetiracetam bulk spot prices rose from June levels (USD 29,888/MT CFR Los Angeles). Key drivers included persistent import-related expenses, elevated container freight rates, and firm downstream demand sentiment.

Price Change Reasons:

Rising Chinese export quotations.
Elevated freight costs to U.S. ports.
Stable-to-firm downstream pharmaceutical demand allowing importers to pass on higher costs.

Q1 2025 (January-March)

During Q1 2025, the U.S. market showed moderate upward movement. January's price increase was minimal (0.12%) with balanced demand and routine procurement. February saw sharper increases due to a 10% tariff on Chinese imports effective February 4, higher production costs, and intensifying demand. March prices edged higher as Chinese export rates rose amid trade uncertainties.

APAC

Q3 2025

In China, the Levetiracetam Price Index increased 2.83% quarter-over-quarter, reaching USD 30,233.33/MT FOB Shanghai. Spot prices strengthened due to flood-induced plant closures in July and accelerated restocking by overseas buyers.

Price Drivers:

Production disruptions: Plant closures and subsequent restarts impacted supply.
Export demand: Sustained overseas inquiries offset intermittent production restarts.
Cost pressures: Logistics and raw material expenses affected production margins.
Demand Outlook: Steady pharmaceutical offtake and renewed international procurement supported constructive demand. Currency movements and logistics costs influenced export margins, prompting strategic offer adjustments.

Q2 2025

APAC markets saw consistent upward momentum from April to July, driven by tightening inventories, reduced output, and sustained export demand. Spot prices for June were USD 29,700/MT CFR Los Angeles.

◼ Track Daily Levetiracetam Price Updates and Strengthen Your Procurement Decisions: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Levetiracetam

Key Influences:

Domestic inventory tightness and lower production output.
Strong international demand from the US and Southeast Asia.
Currency pressures and higher raw material and energy costs during peak summer operations.
Q1 2025

Q1 2025 saw gradual price increases, with January up 0.28%, driven by stable output from GMP-compliant facilities. February experienced sharper increases due to low inventories, rising production costs, and tariffs on exports to the U.S. March continued upward as international demand and constrained raw material availability maintained price strength.

Europe

Q3 2025

Germany's Levetiracetam market showed a 2.64% quarter-over-quarter increase, with the average price at USD 30,270.67/MT CFR Hamburg. Spot prices softened temporarily as Asian exporters eased offers and domestic inventories remained high.

Price Drivers:

Import costs: Earlier freight charges raised landed costs, though subsequent stabilization helped.
Inventory levels: Elevated German stocks and cautious buying limited fresh orders.
Export demand: Softer export demand and steady supplier rates influenced transactional activity.
Demand Outlook: Positive, supported by German pharmaceutical manufacturing and new order volumes. Forecast indicates mild recovery driven by restocking and steady procurement.

Q2 2025

European price indices exhibited mild upward movement in July, continuing the positive trend from May and June. Influences included persistent import cost inflation, firm pharmaceutical demand, elevated freight rates, and tight inventory levels.

Q1 2025

In Q1 2025, the German market experienced steady upward pricing, driven by early procurement before Lunar New Year supply disruptions, low inventory levels, strong downstream demand, and import price increases from China. Prices rose incrementally each month amid euro depreciation and elevated freight charges.

◼ Unlock Live Pricing Dashboards for Accurate and Timely Insights: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Levetiracetam

Historical Quarterly Review

Q4 2024

North America: Stable pricing, balanced supply and demand, routine procurement patterns.
APAC: Remarkable stability; production and exports balanced, inventory positions managed effectively.
Europe: Stable pricing; adequate availability, controlled production rates, and consistent order flows.

Q1 2025

Gradual price increases across all regions due to tariffs, supply constraints, and steady pharmaceutical demand.
China faced tight inventories, logistical friction, and currency effects.
Germany experienced incremental increases due to strategic procurement and import pricing pressures.

Q2 2025

North America and Europe saw moderate upward trends due to import cost inflation and freight variations.
APAC maintained bullish momentum driven by strong export demand and production constraints.

Q3 2025

Global prices rose quarter-over-quarter; North America and Europe benefitted from restocking activity.
APAC prices surged temporarily due to production disruptions, flooding events, and accelerated overseas procurement.
Production and Cost Structure Insights

Levetiracetam pricing is strongly influenced by production costs in Asia, particularly China. Key cost components include:

Raw materials: Fluctuations in precursor chemicals and energy costs impact margins.
Freight and logistics: Rising container freight rates significantly affect landed costs in North America and Europe.
Export offers: Chinese suppliers maintain pricing discipline based on inventory levels and production quotas.
Currency effects: USD depreciation against RMB increases landed costs for U.S. buyers, while Euro strength offers partial relief in Europe.
Manufacturing capacity has generally remained stable, with intermittent disruptions due to environmental events (e.g., floods) or seasonal plant shutdowns.

Procurement Outlook

Procurement behavior varies regionally:

North America: Buyers maintain strategic stock levels and adopt cautious purchasing amid elevated import costs.
APAC: International buyers actively monitor restarts after production disruptions, balancing inventory replenishment with spot price volatility.
Europe: Buyers engage in measured restocking, with focus on mitigating elevated inventory risks and optimizing landed cost efficiencies.
Price forecasts for the coming quarters suggest a moderate upward bias, driven by restocking, firm pharmaceutical demand, and constrained Asian export availability.

FAQ: Levetiracetam Price and Market Dynamics

Q1: Why did Levetiracetam prices rise in North America in Q3 2025?
A1: Higher import costs, elevated freight charges, constrained Asian export availability, and steady downstream pharmaceutical demand drove prices upward. Strategic restocking and elevated inventories influenced spot market volatility.

Q2: What caused price volatility in China during Q3 2025?
A2: Flood-induced plant closures, subsequent restarts, elevated logistics and raw material costs, and fluctuations in international procurement demand contributed to price volatility.

Q3: Why did German prices increase in Q3 2025 despite elevated inventories?
A3: Import cost inflation, steady pharmaceutical demand, and restocking activity supported prices, while cautious buyer behavior and soft export demand moderated spot transactions.

Q4: How do freight and logistics impact Levetiracetam pricing?
A4: Rising container freight rates from Asia increase landed costs in North America and Europe, affecting procurement margins and offering prices. Stabilized freight can ease cost pressures temporarily.

Q5: What is the outlook for Levetiracetam pricing in the near term?
A5: Moderate upward movement is expected, supported by firm pharmaceutical demand, strategic restocking, and constrained export availability from Asia. Volatility may persist due to logistics and environmental factors.

How ChemAnalyst Supports Buyers

ChemAnalyst provides unparalleled market intelligence for chemical buyers, including Levetiracetam. Our services include:

Real-time market news: Continuous updates on prices, supply conditions, and trade flows.
Weekly price updates: Track global trends and quarterly movements to inform procurement strategy.
Price forecasts: Anticipate market movements and optimize purchase timing.
Supply-chain monitoring: Alerts on plant shutdowns, logistics disruptions, and export constraints.
Expert analysis: Insights from chemical engineers and analysts with backgrounds in manufacturing, economics, and trading.
Global coverage: Offices in Houston, Cologne, and New Delhi, with ground teams at 50+ major trading ports, ensure firsthand market intelligence.
By leveraging ChemAnalyst, procurement teams can make informed decisions, mitigate supply risks, and achieve cost efficiencies in sourcing Levetiracetam and other APIs.

◼ Stay Updated Each Day with Verified Levetiracetam Price Movements: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Levetiracetam

Conclusion

The Levetiracetam market demonstrates a complex interplay of supply constraints, import costs, freight fluctuations, and strong pharmaceutical demand. Q3 2025 saw synchronized upward price movements across North America, APAC, and Europe, reflecting both regional and global dynamics. Historical data from Q4 2024 through Q3 2025 highlights the impact of tariffs, currency fluctuations, environmental disruptions, and strategic restocking on price behavior.

Procurement professionals must remain vigilant to regional market conditions, production cost trends, and trade-flow developments. Leveraging real-time data and forecasts, such as those provided by ChemAnalyst, enables buyers to optimize sourcing, minimize risk, and respond effectively to dynamic global market conditions.

Contact Us:

UNITED STATES

Call +1 3322586602

420 Lexington Avenue, Suite 300, New York, NY,

United States, 10170

Germany

Call +49-221-6505-8833

S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Website: https://www.chemanalyst.com/

About Us:

Welcome to ChemAnalyst, a next-generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as "Product Innovator of the Year 2023" and ranked among the "Top 100 Digital Procurement Solutions Companies," we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

This release was published on openPR.